Syndax Pharmaceuticals Inc (NASDAQ: SNDX): Analyst View Points To Future Growth
Syndax Pharmaceuticals Inc (SNDX) concluded trading on Thursday at a closing price of $12.85, with 4.33 million shares of worth about $55.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.91% during that period and on December 19, 2024 the price saw a […]
Syndax Pharmaceuticals Inc (SNDX): Not A Time To Panic Nor Freeze
Syndax Pharmaceuticals Inc (SNDX) concluded trading on Thursday at a closing price of $15.60, with 4.63 million shares of worth about $72.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.43% during that period and on November 21, 2024 the price saw a […]
Syndax Pharmaceuticals Inc (NASDAQ: SNDX) – Suitable For Long Term Buy?
Currently, there are 84.83M common shares owned by the public and among those 79.69M shares have been available to trade. The company’s stock has a 5-day price change of -17.67% and -17.21% over the past three months. SNDX shares are trading -24.99% year to date (YTD), with the 12-month market performance up to 19.63% higher. […]
Institutional Exposure To Syndax Pharmaceuticals Inc (SNDX)
Wellington Management Co. LLP has recently announced that it has increased stake in Syndax Pharmaceuticals Inc (NASDAQ:SNDX) by 2.66%. After grabbing 7.64 million shares, the institutional investor is now in possession of 0.2 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.50% having worth around $165.15 million. […]
